CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY

Post-LOE

cetirizine hydrochloride

Jubilant Therapeutics
ANDAORALTABLET, CHEWABLE
Approved
Feb 2015
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
2

Indications (4)

these symptoms due to hay feverother upper respiratory allergies: runny nose sneezing itchywatery eyes itching of the nosethroat

Clinical Trials (2)

NCT04189588Phase 2Completed

Phase 2 Study IV QUZYTTIR™ (Cetirizine Hydrochloride Injection) vs V Diphenhydramine

Started Mar 2020
NCT00881127Phase 1Completed

To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fasting Conditions

Started Jul 2005
Company
JT
Jubilant Therapeutics
PA - Yardley
10 open jobs
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers